Barriers and Consequences of Prior Authorization for Neurologic Medications
According to the results of this scoping review, PA can contribute to significant access barriers for people with neurological conditions and is associated with burden for all stakeholders involved. Reforms to PA can work towards more equitable access to medications for patients.
Authors
- Leah J. Blank (ORCID: https://orcid.org/0000-0001-8719-6752)
- Blessymol Joseph
- Evelyn Gotlieb (ORCID: https://orcid.org/0000-0002-9809-4046)
- Nathalie Jetté (ORCID: https://orcid.org/0000-0003-1351-5866)
Institutions
- University of Calgary (CA)
- Flinders University (AU)
- Cornell University (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- JAMA Neurology
- Published
- 2025-12-08
- DOI
- https://doi.org/10.1001/jamaneurol.2025.4560
- Citations
- 2
- Primary Topic
- Medication Adherence and Compliance
- Type
- article
- Field-Weighted Citation Impact
- 3.03